Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Sales | 924 | 826 | 1,636 | 1,503 | 1,932 |
| Cost of Goods | 620 | 440 | 810 | 300 | 580 |
| Gross Profit | 300 | 370 | 820 | 1,230 | 1,340 |
| Operating Expenses | 1,460 | 1,210 | 1,560 | 1,470 | 1,370 |
| Operating Income | -536 | -384 | 76 | 33 | 562 |
| Other Income | 36 | 54 | 44 | 87 | 38 |
| Pre-tax Income | -500 | -330 | 120 | 120 | 600 |
| Income Tax | -230 | -100 | 50 | 40 | 250 |
| Net Income Continuous | -268 | -238 | 78 | 72 | 354 |
| Net Income | $-268 | $-238 | $78 | $72 | $354 |
| EPS Basic Total Ops | -0.09 | -0.08 | 0.03 | 0.02 | 0.12 |
| EPS Basic Continuous Ops | -0.09 | -0.08 | 0.03 | 0.02 | 0.12 |
| EPS Diluted Total Ops | -0.09 | -0.08 | 0.03 | 0.02 | 0.12 |
| EPS Diluted Continuous Ops | -0.09 | -0.08 | 0.03 | 0.02 | 0.12 |
| EBITDA(a) | $-446 | $-284 | $176 | $133 | $982 |